BIOR - Biora Therapeutics GAAP EPS of $0.03 beats by $0.15 revenue of $0.9M August, 15 2022 04:46 PM Biora Therapeutics Inc. Biora Therapeutics press release ( NASDAQ: BIOR ): Q2 GAAP EPS of $0.03 beats by $0.15 . Revenue of $0.9M (+95.7% Y/Y). Shares -1.9% . For further details see: Biora Therapeutics GAAP EPS of $0.03 beats by $0.15, revenue of $0.9M